be_ixf;ym_202404 d_24; ct_50

Latest Insights on GILD

Invest in Biotech With 1 Buy (9-minute video) In the war against COVID-19, American biotech companies are paving the path. The latest success is Gilead’s remdesivir winning FDA approval. Will this be the start of a new uptrend for the stock?
An unexpected decline in new home sales and spiking COVID cases spooked Wall Street. But you Great Ones have options to ride out this storm. Pandemic Options; Billionaire Ant Hill; Dunkin Munchkin Huntin’
by Joseph Hargett October 26, 2020 Great Stuff
Risk on; Risk off The global economy is sick … and I mean that literally, not in the ‘90s kinda way or in a Michael Jackson’s “Bad is good” kinda way. Over the weekend, the U.S. hit back-to-back record highs for new COVID-19 cases. According to Johns Hopkins University data, the seven-day average of new […]
Despite Hidden Joblessness, Wall Street Bets Big on Change [15-minute video] Look to earnings, not employment, to position your portfolio for gains next year.
Just when we got going with Nikola, another Hindenburg crash awaits. Gee, who knew hydrogen could be so volatile? Burning Shorts: No More Mr. Nice Nikola
by Joseph Hargett September 14, 2020 Great Stuff
Where the Down Boys Go Last week, I promised we’d look into Great Stuff Pick Nikola Corp. (Nasdaq: ) and the Hindenburg/Citron disaster. Now that the little voice inside my head isn’t trying to kill me anymore, let’s get right to that… I want to start off by making one thing crystal clear: I don’t […]
Forget the market — today is all about YOU! Your questions, your emails, your snide remarks … and your triple-digit gains on CrowdStrike! Praise for CrowdStrike’s Beat and Raise; Set Our Inbox Ablaze!
by Joseph Hargett September 3, 2020 Great Stuff
Strike Hard, Strike Fast Welcome once again to Great Stuff’s Reader Feedback day! Today is all about you. Even this opening section of Great Stuff is about you. That is … unless you don’t trade the Great Stuff Picks portfolio. Then it’s not all about you. But them’s the breaks when you don’t take advantage […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

Share This